PADA SISTEM PERKEMIHAN Kusman Ibrahim, Ph.D. Kusman Ibrahim, Ph.D. Kusman Ibrahim, Ph.D. Kusman Ibrahim, Ph.D. Bagian Keperawatan Klinik FAKULTAS ILMU KEPERAWATAN UNIVERSITAS PADJADJARAN GENERAL STRATEGY ASSESSMENT PRIMARY SURVEY A : AIRWAY AND CERVICAL SPINE B : BREATHING C : CIRCULATION D : DISABILITY (NEUROLOGICAL STATUS) LEVEL OF CONSCIOUSNESS GLASGOW COMA SCALE A : ALERT, AWAKE V : VERBAL P : PAIN U : UNRESPONSIVE 2 SECONDARY SURVEY E : EXPOSURE F : FREEZING/FAHRENHEIT G : GET VITALS SIGN H : HEAD TO TOE, HISTORY I : INSPECT THE POSTERIOR SURFACE PSYCHOLOGICAL, SOCIAL AND ENVIROMENTAL RISK FACTORS PERSONAL HABITS : UNPROTECTED SEXUAL ACTIVITY MULTIPLE SEXUAL PARTNERS NEW SEXUAL PARTNER IN LAST 2 MONTHS FLUID INTAKE IMMOBILITY POOR PERINEAL HYGIEN OTHER RISK FACTORS: PREGNANCY DIABETES GOUT SPINAL CORD INJURY PREVIOUS INFECTIONS RECENT GENITOURINARY INSTRUMENTATION PRESSENCE OF PELVIC FRACTURE 3 FOCUSED SURVEY SUBJECTIVE DATA : HISTORY OF PRESENT ILLNESS : PAIN PQRST DISCHARGE VAGINAL, URETHRAL, RECTAL CHANGE IN URINARY ELIMINATION PATTERNS INJURY FEVER AND CHILLS CHANGE IN EATING / FEEDING PATTERN TISSUE / SKIN CHANGES LETHARGY OR IRRITABILITY SEXUAL HISTORY MEDICAL HISTORY TRAUMA SURGERY / URETHRAL INSTRUMENTATION RENAL DESEASE STDS CURRENT MEDICATION & MEDICATION ALLERGIES 4 OBJECTIVE DATA PHISICAL EXAMINATION GENERAL SURVEY : GENERAL APPEARANCE LEVEL OF CONSCIOUSNESS VITAL SIGNS INSPECTION : GUARDING WITH MOVEMENT WOUND ---- OPEN OR CLOSED PRESENCE OF VISIBLE FOREIGN OBJECTS ODOR PRESENCE OF DISCHARGE, BLEEDING, INFLAMMATION, RASH, LESSIONS ASYMETRY OR DEFORMITY OF AFFECTED PART AUSCULTATION : BOWEL SOUND FETAL HEART TONES IF PREGNANT PERCUSSION BLADDER DISTENSION COSTOVERTEBRAL ANGLE (CVA) TENDERNESS PALPATION AREA OF TENDERNESS ABDOMEN TESTES 5 DIGNOSTIC PROCEDURES : LABORATORY STUDIES URINALYSIS, URIN STONE ANALYSIS, BUN/CREATININE, BLOOD COUNT, PT/PTT RADIOGRAPHIC STUDIES ABDOMEN / KUB, CYSTOGRAM, IVP, USG, CT SCAN SELDOM OCCURS INDEPENDENTLY, SHOULD BE CONSIDERED IN ANY PATIENT PRESENTING WITH CHEST, ABDOMINAL OR BACK TRAUMA HIGH INCIDENCE WITH VERTEBRAL & FLANK INJURIES 6 MINOR CONTUSION CORTICAL LACERATION FORNICEAL DISRUPTION PATHOPHYSIOLOGY RENAL TRAUMA MAJOR DEEP PARENCHYMAL INJURY WITH INTACT CAPSUL DEEP PARENCHYMAL INJURY WITH DISRUPTED CAPSUL SHATTERED KIDNEY WITH INTACT CAPSUL SHATTERED KIDNEY WITH DISRUPTED CAPSUL URETERAL/RENAL PELVIC INJURY PEDICLE INJURY (RENAL ARTERY OR VEIN) RENAL DAMAGE HEMORRHAGE HYPOPERFUSION Figure 71-6 Types of blunt renal trauma. Types A and B often respond to nonoperative treatment. Types C and D usually require operative treatment. Although type C injuries often may be operated on in a delayed fashion, unless vascular disruptive injuries are recognized immediately and treated promptly, loss of the kidney usually occurs, and successful repair is rare. (From O'Neill JA Jr: Principles of Pediatric Surgery, 2nd ed. St. Louis, Mosby, 2003, p 173.) 7 Categories of Renal Injuries Michael Federle placed renal injuries into four categories: Minor injury: renal contusion. intrarenal and subcapsular hematoma. minor laceration with limited perinephric hematoma without extension to the collecting system or medulla. small subsegmental infarct. Major injury: major laceration into medulla or collecting system. segmental infarct. Catastrophical injury: Maceration of the kidney Total devascularization due tot arterial occlusion. Rupture collecting system. http://www.radiologyassistant.nl/en/466181ff61073 ASSESSMENT SUBJECTIVE DATA : HISTORY OF PRESENT ILLNESS MECHANISM OF INJURY PAIN, CVA OR ABDOMINAL NAUSEA, VOMITING MEDICAL HISTORY MEDICATIONS ALLERGIES RENAL DESEASES HYPERTENSION HISTORY OF RENAL SURGERY 8 OBJECTIVE DATA : PHYSICAL EXAMINATION GENERAL SURVEI RAPID HR, HYPOTENSION, PALLOR, MOIST AND COOL SKIN IN PRESENCE OF HEMORRHAGE FOCUSED FLANK, ABDOMINAL EXAMINATION RETROPERITONEAL HEMATOMA HEMATURIA GROSS OLIGURIA OR ANURIA CONTUSIONS, ABRASIONS, LACERATIONS BOWEL SOUNDS CVA TENDERNESS DIAGNOSTIC PROCEDURES : COMPLETE BLOOD COUNT WITH DIFFERENTIAL SERIAL HT. SERUM ELECTROLYTES BUN, CREATININE PT/PTT URINALYSIS TYPE AND CROSS MATCH BLOOD ABDOMINAL X-RAY IVP CT SCAN 9 NURSING DIAGNOSIS ALTERED CARDIAC OUTPUT RELATED TO HEMORRHAGE AND DIMINISHED CIRCULATING BLOOD VOLUME TISSUE PERFUSION, ALTERED R.T. HEMORRHAGE PAIN R.T. EFFECTS OF TARUMA RISK FOR INFECTIONS R.T. ALTERATION IN SKIN INTEGRITY ANXIETY R.T. UNKNOWN OUTCOME OF INJURY PLANNING / INTERVENTIONS MAINTAIN AIRWAY, BRETHING, CIRCULATION ESTABLISH LARGE-BORE PERIPHERAL IV ACCESS FOR ADMINISTRATION OF CRISTALLOID MEDICATIONS, POSSIBLE BLOOD PRODUCTS AND DX PROCEDURES CONTINOUSLY MONITOR : HEMODYNAMIC STATUS, NEUROLOGICAL STATUS, TISSUE PERFUSION, PULSE OXIMETRY, INTAKE-OUTPUT PREPARE FOR/ASSIST WITH MEDICAL INTERVENTIONS; BLOOD PRODUCTS TRANSFUSION, RONTHGENT AND DX. STUDIES, SURGERY ADMINISTER PHARMACOLOGICAL THERAPY AS ORDERED; TETANUS TOXOID/SERUM, ANALGESICS, ANTIBIOTICS ALLOW SUPORTIVE SIGNIFICANT OTHER TO REMAIN WITH PATIENT AND PARTICIPATE IN CARE AS APPROPRIATE 10 TERMINOLOGY: ARF : THE ABRUPT FALL OR CESATION OF URINE VOLUME AND THE RETAINMENT OF METABOLIC WASTE PRODUCTS. ACUT TUBULAR NECROSIS (ATN): CLINICAL SYNDROME OF ARF SECONDARY TO ISCHEMIA OR TOXIC INJURY TO THE RENAL TUBULES AZOTEMIA: AN EXCESS OF METABOLIC WASTE PRODUCT IN THE BLOOD; UREA, NITROGEN, CREATININ OLIGURIA: URINE VOLUME < 400 ML/24 HOURS RENAL INSUFFICIENCY: A COMPROMISED STATE OF KIDNEY FUNCTION IN THE ABSENCE OF CLINICAL MANIFESTATIONS. LABORATORY TESTS INDICATE DETERIORATION OF NEPHRONIC FUNCTION. TYPES OF ACUT RENAL FAILURE PRERENAL FAILURE RENAL FAILURE POSRENAL FAILURE 11 PRERENAL FAILURE OCCURS WHEN THERE IS DECREASE IN EFFECTIVE ARTERIAL BLOOD VOLUME PERFUSING THE KIDNEY CAUSES VOLUME DEPLETION HEMORRHAGE, FLUID LOSSES FROM SKIN, GIT, DIURETICS CO CHF, PERICARDIAL TAMPONADE, ARRHYTHMIAS ALTERED VASCULAR RESISTANCE VASODILATING DRUGS, CA CHANNEL BLOCKER, ACE INHIBITORS, SEPSIS RENAL FAILURE RENAL FUNCTION LOSS OCCURS SECONDARY TO STRUCTURAL DAMAGE WITHIN THE KIDNEY CAUSES GLOMERULONEPHRITIS VASCULAR LESIONS (INFLAMATORY, TROMBOEMBOLIC), RENAL ARTERI STENOSIS INTERSTITIAL NEPHRITIS (INFECTIOUS OR ALLERGIC) ATN 12 POSTRENAL FAILURE IT IS CAUSED BY CONDITIONS THAT ABSTRUCT URINE FLOW CAUSES URINARY CALCULI, COLLECTING SYSTEM CLOTS, STRICTURE, HYPERTROPHIED PROSTATE MECHANICAL OBSTRUCTION BY KINKING OF THE INDWELLING CATHETER PHASES OF ACUT RENAL FAILURE OLIGURIC PHASE: DAILY URINE OUTPUT < 400 ML COMPLICATIONS OVERHYDRATION ACCOMPANIED BY CARDIAC FAILURE, PULMONARY EDEMA, ACIDOSIS, HYPERKALEMIA, UREMIC SYMPTOMS DIURETIC PHASE: INCREASE OF URINE VOLUME, OSMOTIC DIURESIS HIGH LEVEL OF UREA INABILITY OF THE KIDNEYS TO CONSERVE SODIUM & WATER RECOVERY PHASE: THE FILTRATING & CONCENTRATING OF KIDNEYS RESTORED 13 CLINICAL DATA LABORATORY TEST: URINALYSIS IN RENAL FAILURE: URINE SODIUM , SPECIFIC GRAVITY AND OSMOLALITY , URINE SEDIMENT; CAST(+), WBC(+), RBC (+) BUN (N: 8-25 MG/100 ML) PRERENAL, RENAL, POSTRENAL FAILURE BUN BUN OVERHYDRATION, SEVERE LIVER DAMAGE, A DIET LOW IN PROTEIN CREATININ (N: 0,6 1,2 MG/100 ML) CRETAININ 2X N 50 % NEPHRON LOSS, 8X N 75 % LOSS OF NEPHRONIC FUNCTION BUN-CREATINI RATIO 10 : 1 DIAGNOSTIC TESTS CYTOSCOPY IVP X-RAY --- KUB RENAL ANGIOGRAPHY RENAL USG 14 SYSTEMIC CONSEQUENCES OF ARF ELECTROLYTE IMBALANCES HYPERKALEMIA METABOLIC ACIDOSIS KUSMAUL BREATHING, ANOREXIA, NAUSEA, CONFUSION, SHORTENED MEMORY AND ATTENSION SPAN, STUPOR OR COMA, IF CONTINUOUS --- CARDIOVASCULAR EFFECS; CO , BP , ARRHYTHMIAS INFECTION MACROPHAGE ACTIVITY E.C. UREMIC TOXINS UREMIA NEUROLOGICAL SIGNS; CONFUSION, CONVULSIONS, COMA, CHANGE IN SENSORIUM GIT; ANOREXIA, VOMITING, BLEEDING INFECTIONS BRUISING AND BLEEDING BLOOD COAGULATION FACTOR DYSFUNCTION ANEMIA; ERYTHROPOIETIN ,ERYTHROCYTE DESTRUCTION VOLUME OVERLOAD NURSING MANAGEMENT NURSING DIAGNOSIS FLUID VOLUME DEFICIT R.T. HYPOVOLEMIA (EXTRACELLULAR DEHYDRATION), HYPERNATREMIA (INTRACELLULAR DEHYHRATION) FLUID VOLUME, ALTERATION IN: EXCESS ( EC OVERHYDRATION, HYPERVOLEMIA, CIRCULATORY OVERLOAD) ELECTROLYTE IMBALANCE R.T. : WATER DEFICIT / WATER EXCESS, HYPERNATREMIA / HYPONATREMIA CARDIAC OUTPUT, ALTERATION IN : DECREASE R.T. :DYSRYTHMIAS, HYPERKALEMIA ( > 5.5 MEQ/L), HYPOKALEMIA ( < 3.5 MEQ/L) 15 NURSING DIAGNOSIS (Cont.) ACID-BASE BALANCE: ALTERATION IN, R.T. METABOLIC ACIDOSIS NUTRITION, ALTERATION IN : LESS THAN BODY REQUIREMENTS INFECTION, POTENTIAL FOR : DEPRESSED IMMUNOLOGIC SYSTEM INJURY, POTENTIAL FOR : UREMIA-INDUCED G.I DISORDERS COMFORT, ALTERATION IN : PAIN (PERICARDITIS) KNOWLEDGE DEFICIT : DIETARY REGIMEN IN RENAL DISEASE ACTIVITY ALTERATION IN : FATIGUE AND ANEMIA COPING INEFFECTIVE INDIVIDUAL / FAMILY ; POTENTIAL NURSING INTERVENTIONS ASSESS IMPACT OF FLUID VOLUME DEFICIT ON BODY PROCESSES ASSESS NEUROLOGIC STATUS; LEVEL OF CONSCIOUSNESS, BEHAVIORAL CHANGE (IRRITABILITY, RESTLESSNESS, LETHARGY) ASSESS STATUS OF HEMODYNAMIC FUNCTION ; HR, PERIPHERAL PULSES, TACHYPNEA, POSTURAL HYPOTENSION, CVP MONITOR BODY TEMPERATURE; FEVER ASSESS RENAL FUNCTION; BUN, CREATININE, URINE OUTPUT, SG > 1.030, INTAKE-OUTPUT ASSESS GI FUNCTION; ANOREXIA, NAUSEA, VOMITING, ABDOMINAL CRAMPS AND DISTENTION, DIARRHEA ASSESS BODY WEIGHT (DAILY) COLLABORATE WITH PHYSICIAN TO CORRECT UNDERLYING CAUSE OF FLUID IMBALANCE 16 NURSING INTERVENTIONS (Cont.) IMPLEMENT FLUID REPLACEMENT REGIMEN; ECF : SALINE DEFICIT (HYPONATREMIA): SALINE FLUID REPLACEMENT ORALLY OR IV UNTILL OLIGURIA IS RELIEVED, HEMODYNAMIC STABILIZE,NEUROLOGIC STATUS IS ANTACT, MONITOR REHYDRATION, INSERT FOLEY CATHETER, MONITOR FOR SIGNS OF FLUID EXCESS. ICF DEFICIT, WATER DEFICIT (HYPERNATREMIA): ASSESS NEUROLOGIC FUNCTION: WEAKNESS, RESTLESSNESS, IRRITABILITY, HYPERPNEA, TETANY WATER REPLACEMENT ORALLY OR IV WITH 5 % DEXTROSE, AVOID FURTHER WATER LOSS, KEEP PATIENT AND ENVIROMENT COOL, USE ANTIPYRETICS MAY BE INDICATED FOR FEVER MONITOR SERUM SODIUM LEVELS, SERUM PROTEINS, URINARY SODIUM, URINE SPECIFIC GRAVITY MEDICAL MANAGEMENT OLIGURIC PHASE CONTROL FLUIDS, PREVENT TISSUE CATABOLISM, ENHANCE WASTE PRODUCT EXRETION, REGULATE ELECTROLYTE COMPOSITION. THERAPY; DYALISIS, FLUID AND DIETARY RESTRICTION (K , PROTEIN ,CARBOHYDRATE ), TPN ( AMINO ACID ,GLUCOSA ), KAYEXALATE, NAHCO3, ANTIBIOTICS, MINIMAL USE INVASIVE LINES AND CATHETER DIURETIC PHASE; REGULATION OF ELECTROLYTES, MAINTENANCE OF FLUID VOLUME, DIETARY RESTRICTIONS 17 DIALYSIS IN ARF, INDICATIONS: URAEMIC SYMPTOMS, e.g.,PERICARDITIS VOLUME OVERLOAD HYPERKALEMIA METABOLIC ACIDOSIS CONTINUOUS RENAL REPLACEMENT THERAPY THREE CATEGORIES: SLOW CONTINUOUS ULTRAFILTRATION (SCUF) CONTINUOUS HEMOFILTRATION (CAVH, CVVH) CONTINUOUS (AV,VV) HAEMODIALYSIS AND PERITONEAL DIALYSIS 18 19 MANAGEMENT OF SPECIFIC CONDITIONS HYPERKALEMIA HEMODIALYSIS ORAL OR RECTAL POTASSIUM EXCHANGE AGENTS (CALCIUM RESONIUM) INTRAVENOUS INSULIN + DEXTROSE VOLUME OVERLOAD FLUID INTAKE RESTRICTIONS (EQUAL THE DAILY URINE OUTPUT PLUS 300-500 Ml) DALYSIS METABOLIC ACIDOSIS LIMITING THE LEVEL INTAKE OF PROTEIN INFUSE SODIUM BICARBONATE BE AWARE FLUID OVERLOAD & HYPERNATREMIA BICARBONATE HD DONOR : AGE ; 0 75 YEARS CONTRAINDICATIONS HISTORY OF INVASIVE CANCER, PRESENCE UNTREATED SYSTEMIC BACTERIAL, VIRAL OR FUNGAL INFECTIONS, HIV ANTIBODY (+), HBSAG (+) RECIPIENT : HUMAN LEUKOCYTE ANTIGEN (HLA) MATCHING BETWEEN DONOR RECIPIENT ABO BLOOD GROUP CROSSMATH REVIEV OF ALL BODY SYSTEMS CV PSYCHOLOGICAL & IMMUNOLOGIC EVALUATION 20 TRANSPLANT REJECTION : HYPERACUTE REJECTION (MINUTE HOURS) ACCELERATED REJECTION (FIRST WEEK) ACUTE REJECTION A CELL MEDIATED RESPONSE; T , GENERAL MALAISE, TENDERNESS OVER GRAFT, BP , URINE OUTPUT , PERIPHERAL EDEM, BW CRONIC REJECTION A HUMORAL RESPONSE; RENAL FUNCTION (MONTHS YEARS) IMMUNOSUPPRESSION : CYCLOSPORINE PREVENT REPLICATION OF T LYMPHOCYTES BY INHIBITING THE PRODUCTION INTERLEUKIN-2 ANTILYMPHOCYTE GLOBULIN (ALG) USED TO TREAT ACUT REJECTION BY DESTROYING THE CIRCULATORY LYMPHOCYTES PREDNISONE AZATHIOPRINE INHIBITING PROLIFERATION OF LYMPHOCYTES 21 Clinical Management Clinical Management Preoperative: Preoperative: Provide Provide routine preoperative routine preoperative care care Assess Assess knowledge and feelings about the knowledge and feelings about the procedure, procedure, answering questions answering questions and clarifying and clarifying information as needed. Listen information as needed. Listen and address and address concerns about surgery, the source of the donor concerns about surgery, the source of the donor organ and organ and possible complications. possible complications. Continue Continue dialysis as ordered. dialysis as ordered. Administer Administer immunosuppressive drugs as immunosuppressive drugs as ordered before ordered before surgery surgery Clinical Management Clinical Management Postoperative: Postoperative: Provide Provide routine postoperative routine postoperative care care Maintain Maintain urinary catheter patency and a closed urinary catheter patency and a closed system. system. Measure Measure urine output every 30 to 60 minutes urine output every 30 to 60 minutes initially. initially. Monitor Monitor vital signs and hemodynamic pressures vital signs and hemodynamic pressures closely. closely. Maintain Maintain fluid replacement, generally calculated fluid replacement, generally calculated to to replace urine replace urine output over the previous 30 or output over the previous 30 or 60 minutes, milliliter 60 minutes, milliliter for milliliter for milliliter. . Administer Administer diuretics as ordered. diuretics as ordered. 22 Clinical Management Clinical Management Postoperative: Postoperative: Remove the catheter within 2 to 3 days or as Remove the catheter within 2 to 3 days or as ordered. Encourage to void every 1 to 2 hours ordered. Encourage to void every 1 to 2 hours and assess frequently for signs of urinary and assess frequently for signs of urinary retention following catheter removal. retention following catheter removal. Monitor serum electrolytes and renal function Monitor serum electrolytes and renal function tests. tests. Monitor for possible complications: Monitor for possible complications: Hemorrhage Hemorrhage Urethral Urethral anastomosis anastomosis failure failure Renal artery thrombosis Renal artery thrombosis infection infection Health Education Health Education The use and effects of prescribed medications, including The use and effects of prescribed medications, including antihypertensive medications, immunosuppressive agents, antihypertensive medications, immunosuppressive agents, prophylactic antibiotics, and others as ordered. prophylactic antibiotics, and others as ordered. Monitoring vital signs (including temperature) and weight. Monitoring vital signs (including temperature) and weight. Manifestations of organ rejection, such as swelling and Manifestations of organ rejection, such as swelling and tenderness over the graft site, fever, joint aching, weight tenderness over the graft site, fever, joint aching, weight gain, and decreased urinary output. Stress the importance gain, and decreased urinary output. Stress the importance of promptly reporting signs and symptoms to the physician. of promptly reporting signs and symptoms to the physician. Ordered or recommended dietary restrictions such as Ordered or recommended dietary restrictions such as restricted carbohydrate and sodium intake, and increased restricted carbohydrate and sodium intake, and increased protein intake. protein intake. Measures to prevent infection, such as avoiding crowds and Measures to prevent infection, such as avoiding crowds and obviously ill individuals. obviously ill individuals. Provide Provide psychologic psychologic support, address concerns, and provide support, address concerns, and provide information as needed information as needed 23 Terima Kasih Terima Kasih Terima Kasih Terima Kasih